After digesting Emulex's (ELX +14.3%) FQ2 report and rosy guidance, analysts are turning more...

|About: Emulex Corporation (ELX)|By:, SA News Editor

After digesting Emulex's (ELX +14.3%) FQ2 report and rosy guidance, analysts are turning more bullish. Kaufman initiates coverage with a Buy rating and $12 price target, while ThinkEquity moves its rating up to Buy from Hold. A more restrained Goldman Sachs came in with a modest increase in its PT on shares to $8 - a mark that has already been eclipsed.